- Home
- FRSH vs AXSM Comparison
FRSH vs AXSM Comparison
Compare FRSH & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSH
- AXSM
- Stock Information
- Founded
- FRSH 2010
- AXSM 2012
- Country
- FRSH United States
- AXSM United States
- Employees
- FRSH N/A
- AXSM N/A
- Industry
- FRSH EDP Services
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- FRSH Technology
- AXSM Health Care
- Exchange
- FRSH Nasdaq
- AXSM Nasdaq
- Market Cap
- FRSH 4.1B
- AXSM 4.0B
- IPO Year
- FRSH 2021
- AXSM 2015
- Fundamental
- Price
- FRSH $11.19
- AXSM $91.03
- Analyst Decision
- FRSH Buy
- AXSM Strong Buy
- Analyst Count
- FRSH 15
- AXSM 14
- Target Price
- FRSH $19.47
- AXSM $124.57
- AVG Volume (30 Days)
- FRSH 2.0M
- AXSM 421.5K
- Earning Date
- FRSH 10-29-2024
- AXSM 11-04-2024
- Dividend Yield
- FRSH N/A
- AXSM N/A
- EPS Growth
- FRSH N/A
- AXSM N/A
- EPS
- FRSH N/A
- AXSM N/A
- Revenue
- FRSH $652,935,000.00
- AXSM $291,489,000.00
- Revenue This Year
- FRSH $21.46
- AXSM $42.50
- Revenue Next Year
- FRSH $17.04
- AXSM $69.28
- P/E Ratio
- FRSH N/A
- AXSM N/A
- Revenue Growth
- FRSH 19.87
- AXSM 59.73
- 52 Week Low
- FRSH $10.96
- AXSM $55.02
- 52 Week High
- FRSH $24.98
- AXSM $98.40
- Technical
- Relative Strength Index (RSI)
- FRSH 39.12
- AXSM 55.83
- Support Level
- FRSH $11.05
- AXSM $91.52
- Resistance Level
- FRSH $11.75
- AXSM $96.56
- Average True Range (ATR)
- FRSH 0.33
- AXSM 2.95
- MACD
- FRSH -0.02
- AXSM 0.13
- Stochastic Oscillator
- FRSH 11.86
- AXSM 44.47
About FRSH Freshworks Inc.
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.